Antigenic targets in clear cell renal cell carcinoma

被引：2

作者：

Schindler, Nicholas R. ^{[1
,2
]}

Braun, David A. ^{[1
,2
]}

机构：

[1] Yale Sch Med, Dept Internal Med, Sect Med Oncol, New Haven, CT USA

[2] Yale Sch Med, Yale Canc Ctr, Ctr Mol & Cellular Oncol, New Haven, CT USA

来源：

KIDNEY CANCER | 2023年 / 7卷 / 01期

关键词：

Renal cell carcinoma; tumor antigen; neoantigen; cancer vaccine; T cell receptor; chimeric antigen receptor T cell; TUMOR-INFILTRATING LYMPHOCYTES; CYTOLYTIC T-LYMPHOCYTES; SELECTIVE EXPRESSION; 1ST-LINE THERAPY; CANCER VACCINE; MELANOMA; NEOANTIGENS; SUNITINIB; RESPONSES; IMA901;

D O I：

10.3233/KCA-230006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immune checkpoint inhibitors (ICIs) have transformed the management of advanced renal cell carcinoma (RCC), but most patients still do not receive a long-term benefit from these therapies, and many experience off-target, immune-related adverse effects. RCC is also different from many other ICI-responsive tumors, as it has only a modest mutation burden, and total neoantigen load does not correlate with ICI response. In order to improve the efficacy and safety of immunotherapies for RCC, it is therefore critical to identify the antigens that are targeted in effective anti-tumor immunity. In this review, we describe the potential classes of target antigens, and provide examples of previous and ongoing efforts to investigate and target antigens in RCC, with a focus on clear cell histology. Ultimately, we believe that a concerted antigen discovery effort in RCC will enable an improved understanding of response and resistance to current therapies, and lay a foundation for the future development of "precision" antigen-directed immunotherapies.

引用

页码：81 / 91

页数：11

共 82 条

[71] T-cell quality in memory and protection: implications for vaccine design [J].

Seder, Robert A. ;

Darrah, Patricia A. ;

Roederer, Mario .

NATURE REVIEWS IMMUNOLOGY, 2008, 8 (04) :247-258

[72] Alternative tumour-specific antigens [J].

Smith, Christof C. ;

Selitsky, Sara R. ;

Chai, Shengjie ;

Armistead, Paul M. ;

Vincent, Benjamin G. ;

Serody, Jonathan S. .

NATURE REVIEWS CANCER, 2019, 19 (08) :465-478

[73] 5T4 oncofoetal antigen: an attractive target for immune intervention in cancer [J].

Stern, Peter L. ;

Harrop, Richard .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (04) :415-426

[74] CAR-T cell therapy: current limitations and potential strategies [J].

Sterner, Robert C. ;

Sterner, Rosalie M. .

BLOOD CANCER JOURNAL, 2021, 11 (04)

[75] Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells [J].

Takahashi, Yoshiyuki ;

Harashima, Nanae ;

Kajigaya, Sachiko ;

Yokoyama, Hisayuki ;

Cherkasova, Elena ;

McCoy, J. Philip ;

Hanada, Ken-ichi ;

Mena, Othon ;

Kurlander, Roger ;

Abdul, Tawab ;

Srinivasan, Ramaprasad ;

Lundqvist, Andreas ;

Malinzak, Elizabeth ;

Geller, Nancy ;

Lerman, Michael I. ;

Childs, Richard W. .

JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (03) :1099-1109

[76] Carbonic anhydrase 9 in clear cell renal cell carcinoma: A marker for diagnosis, prognosis and treatment [J].

Tostain, Jacques ;

Li, Guorong ;

Gentil-Perret, Anne ;

Gigante, Marc .

EUROPEAN JOURNAL OF CANCER, 2010, 46 (18) :3141-3148

[77] PD-1 blockade induces responses by inhibiting adaptive immune resistance [J].

Tumeh, Paul C. ;

Harview, Christina L. ;

Yearley, Jennifer H. ;

Shintaku, I. Peter ;

Taylor, Emma J. M. ;

Robert, Lidia ;

Chmielowski, Bartosz ;

Spasic, Marko ;

Henry, Gina ;

Ciobanu, Voicu ;

West, Alisha N. ;

Carmona, Manuel ;

Kivork, Christine ;

Seja, Elizabeth ;

Cherry, Grace ;

Gutierrez, Antonio J. ;

Grogan, Tristan R. ;

Mateus, Christine ;

Tomasic, Gorana ;

Glaspy, John A. ;

Emerson, Ryan O. ;

Robins, Harlan ;

Pierce, Robert H. ;

Elashoff, David A. ;

Robert, Caroline ;

Ribas, Antoni .

NATURE, 2014, 515 (7528) :568-+

[78] Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis [J].

Turajlic, Samra ;

Litchfield, Kevin ;

Xu, Hang ;

Rosenthal, Rachel ;

McGranahan, Nicholas ;

Reading, James L. ;

Wong, Yien Ning S. ;

Rowan, Andrew ;

Kanu, Nnennaya ;

Al Bakir, Maise ;

Chambers, Tim ;

Salgado, Roberto ;

Savas, Peter ;

Loi, Sherene ;

Birkbak, Nicolai J. ;

Sansregret, Laurent ;

Gore, Martin ;

Larkin, James ;

Quezada, Sergio A. ;

Swanton, Charles .

LANCET ONCOLOGY, 2017, 18 (08) :1009-1021

[79] Human Tumor Antigens and Cancer Immunotherapy [J].

Vigneron, Nathalie .

BIOMED RESEARCH INTERNATIONAL, 2015, 2015

[80] Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival [J].

Walter, Steffen ;

Weinschenk, Toni ;

Stenzl, Arnulf ;

Zdrojowy, Romuald ;

Pluzanska, Anna ;

Szczylik, Cezary ;

Staehler, Michael ;

Brugger, Wolfram ;

Dietrich, Pierre-Yves ;

Mendrzyk, Regina ;

Hilf, Norbert ;

Schoor, Oliver ;

Fritsche, Jens ;

Mahr, Andrea ;

Maurer, Dominik ;

Vass, Verona ;

Trautwein, Claudia ;

Lewandrowski, Peter ;

Flohr, Christian ;

Pohla, Heike ;

Stanczak, Janusz J. ;

Bronte, Vincenzo ;

Mandruzzato, Susanna ;

Biedermann, Tilo ;

Pawelec, Graham ;

Derhovanessian, Evelyna ;

Yamagishi, Hisakazu ;

Miki, Tsuneharu ;

Hongo, Fumiya ;

Takaha, Natsuki ;

Hirakawa, Kosei ;

Tanaka, Hiroaki ;

Stevanovic, Stefan ;

Frisch, Juergen ;

Mayer-Mokler, Andrea ;

Kirner, Alexandra ;

Rammensee, Hans-Georg ;

Reinhardt, Carsten ;

Singh-Jasuja, Harpreet .

NATURE MEDICINE, 2012, 18 (08) :1254-+

← 1 2 3 4 5 6 7 8 9 →